$HOOD - Robinhood showing strong growth in platform assets (+50% YoY), Gold subscribers (+36% in Q1), rolling out agentic trading, and cutting workforce by 10% which will lead to capital reallocation to marketing, buybacks, and remaining employees.
$INTC - Intel signed deal with Apple for chip supply and manufacturing, part of broader semiconductor complex strength as US becomes hub for chip production and AI infrastructure.
$MU - Micron positioned to benefit from continued semiconductor demand driven by AI infrastructure buildout and data center expansion.
$HUD - HUD performing well and seen as better play than Hyperliquid, which is being held back by broader crypto weakness despite strong fundamentals.
$BIOTECH - AI revolutionizing biotech through drug discovery and new medical devices, FDA becoming more lax under RFK creating favorable regulatory environment. Multiple catalysts including Midjourney's MRI device and gene therapy approvals.
$ARCG - ARK Genomics ETF as entry point into biotech/genomics megatrend, with plan to increase exposure after further research into AI-driven drug discovery and medical innovation.
$URA - Nuclear revolution expected in US over next 3-5 years driven by new reactor innovations and Trump administration support. Uranium mining companies will benefit from expanded production even if commodity prices don't rise proportionally.
$INFRA - Capital rotating from digital to physical world after 15-20 years of digital focus. AI, robotics, and accumulated wealth driving infrastructure improvements, beautification projects, and demand for physical spaces and IRL events.
Bearish:
$MSTR - MicroStrategy's STRC product in downward spiral, selling equity to fund 11% dividend which compresses premium. No viable exit strategy other than suspending operations, should have refinanced debt instead of buying more Bitcoin.
$BTC - Bitcoin facing headwinds from Robinhood crypto revenue down 47% in Q1, MicroStrategy issues, and strengthening dollar from US-focused capital flows hurting commodities including crypto.
$EM - Emerging markets thesis for 2026 completely failed as AI innovation concentrated in US. Capital should be reallocated away from EM exposure back to US markets.